Lawrence Vandervoort
YOU?
Author Swipe
View article: Prevalence and burden of anhedonia among patients with major depressive disorder in South Korea: A cross-sectional, observational study
Prevalence and burden of anhedonia among patients with major depressive disorder in South Korea: A cross-sectional, observational study Open
Background Anhedonia (ANH), a key symptom of major depressive disorder (MDD), has a substantial societal and economic burden. In South Korea, while MDD is prevalent, the evidence regarding anhedonia remains scarce. This study investigated …
View article: Herpes zoster vaccination and vaccine preferences among persons aged 50–64 years in Australia: Findings from a discrete choice experiment
Herpes zoster vaccination and vaccine preferences among persons aged 50–64 years in Australia: Findings from a discrete choice experiment Open
Vaccine-preventable herpes zoster (HZ) poses substantial burden among Australian adults ≥50 years of age (YOA) despite available vaccination. This study aimed to understand the HZ vaccine-related preferences of adults paying out-of-pocket …
View article: Understanding anhedonia in major depressive disorder in Japan: epidemiology and unmet needs from patients’ and physicians’ perspectives
Understanding anhedonia in major depressive disorder in Japan: epidemiology and unmet needs from patients’ and physicians’ perspectives Open
Background Anhedonia (ANH), one of the core symptoms of major depressive disorder (MDD), poses a significant health challenge. We evaluated the prevalence of ANH among MDD patients in Japan, and elucidated patient journey from patients’ an…
View article: Patient preferences toward herpes zoster vaccination among individuals aged 50 years or older in South Korea: Findings from a discrete choice experiment
Patient preferences toward herpes zoster vaccination among individuals aged 50 years or older in South Korea: Findings from a discrete choice experiment Open
In South Korea, the increasing incidence of herpes zoster (HZ) and aging population warrant consideration of HZ vaccination for older adults. There is a need to understand the HZ vaccine-related preferences of adults aged ≥50 years and adu…
View article: The Impact of Anhedonia on the Disease Burden of Major Depressive Disorder in the Asia–Pacific Region: A Cross‐Sectional Real‐World Study
The Impact of Anhedonia on the Disease Burden of Major Depressive Disorder in the Asia–Pacific Region: A Cross‐Sectional Real‐World Study Open
Aim Anhedonia is a key symptom of major depressive disorder (MDD), however, its burden in patients with MDD is not well understood. We aimed to assess the impact of anhedonia on health‐related quality of life (HRQoL), health‐care resource …
View article: EPIDEMIOLOGY AND BURDEN OF DISEASE OF MAJOR DEPRESSIVE DISORDER (MDD) WITH ANHEDONIA IN ASIA PACIFIC
EPIDEMIOLOGY AND BURDEN OF DISEASE OF MAJOR DEPRESSIVE DISORDER (MDD) WITH ANHEDONIA IN ASIA PACIFIC Open
Background Major depressive disorder (MDD) is a pervasive mental health condition with a substantial global disease burden. Anhedonia is a core symptom of MDD and has been associated with poorer disease prognosis and suboptimal treatment r…
View article: PREVALENCE AND BURDEN OF ANHEDONIA IN KOREAN PATIENTS WITH MAJOR DEPRESSIVE DISORDER
PREVALENCE AND BURDEN OF ANHEDONIA IN KOREAN PATIENTS WITH MAJOR DEPRESSIVE DISORDER Open
Background According to an OECD report, approximately 4 in 10 people in South Korea suffer from a major depressive disorder (MDD) or depressed mood. The prevalence of MDD in Korea was 36.8%, the highest among OECD countries1. Although ther…
View article: Anhedonia in Major Depressive Disorder: Prevalence and Treatment Expectations and Satisfaction with Treatment Goals Among Patients and Physicians in Asia-Pacific
Anhedonia in Major Depressive Disorder: Prevalence and Treatment Expectations and Satisfaction with Treatment Goals Among Patients and Physicians in Asia-Pacific Open
This first large-scale study conducted across the Asia-Pacific region provides a recent update on the prevalence of MDD and anhedonia in MDD and highlights unmet needs in the current therapeutic landscape for anhedonia in MDD, emphasizing …